LLY
$902.71
Revenue | $11302.8Mn |
Net Profits | $2967Mn |
Net Profit Margins | 26.25% |
PE Ratio | 112.41 |
Eli Lilly And Company’s revenue jumped 35.98% since last year same period to $11302.8Mn in the Q2 2024. On a quarterly growth basis, Eli Lilly And Company has generated 28.91% jump in its revenue since last 3-months.
Eli Lilly And Company’s net profit jumped 68.27% since last year same period to $2967Mn in the Q2 2024. On a quarterly growth basis, Eli Lilly And Company has generated 32.28% jump in its net profits since last 3-months.
Eli Lilly And Company’s net profit margin jumped 23.75% since last year same period to 26.25% in the Q2 2024. On a quarterly growth basis, Eli Lilly And Company has generated 2.62% jump in its net profit margins since last 3-months.
Eli Lilly And Company’s price-to-earnings ratio after this Q2 2024 earnings stands at 112.41.
EPS Estimate Current Quarter | 2.6 |
EPS Estimate Current Year | 2.6 |
Eli Lilly And Company’s earning per share (EPS) estimates for the current quarter stand at 2.6 - a 5.69% jump from last quarter’s estimates.
Eli Lilly And Company’s earning per share (EPS) estimates for the current year stand at 2.6.
Earning Per Share (EPS) | 3.92 |
Return on Assets (ROA) | 0.14 |
Return on Equity (ROE) | 0.59 |
Dividend Per Share (DPS) | 1.3 |
Eli Lilly And Company’s earning per share (EPS) jumped 85.78% since last year same period to 3.92 in the Q2 2024. This indicates that the Eli Lilly And Company has generated 85.78% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Eli Lilly And Company’s return on assets (ROA) stands at 0.14.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Eli Lilly And Company’s return on equity (ROE) stands at 0.59.
Eli Lilly And Company declared 1.3 dividend per share during the earnings announcement for Q2 2024.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-08-08 | 2.6 | 3.92 | 50.77% |
2024-04-30 | 2.46 | 2.58 | 4.88% |